Brian Cummings is CEO of the Alta Innovation Institute. Brian has had a successful career in starting hundreds of technology based companies and is passionate about changing the way in which breakthrough technologies get commercialized. He is a Founder and/or CXO of a number breakthrough companies including Mu Therapeutics – developing a novel vaccines for addiction, Technium – a SAAS company that analyzes and aggregates Big Ideas, Tao – a medical device merchant bank,  and Motive – an accelerator based on NISI principles. Brian has generated over $100 million in licensing and ventures revenue and was most recently Vice President of Technology Commercialization at Ohio State University and President of the Ohio State Innovation Foundation.  In that role he transformed the office led the creation of over 20 new entrepreneurial based programs, tripled the number of start-ups, doubled the number of inventions and increased the portfolio valuation over 30 fold.  Previously he was Executive Director of the Technology Commercialization Office at the University of Utah and Associate Vice President for Technology Ventures. Brian has set up multiple seed and venture capital funds and with his partner, Paul Ahlstrom, developed a unique seed funding model called KickStart to align early stage investors.  Previously, Brian led the life science commercialization efforts at the University of Texas and structured one of their largest deals to date. Brian has served on multiple Boards including e-SENS Inc., Tao Ventures, Catheter Connections, The Rocky Mountain Research Center for Emerging Infectious Diseases, The Governor’s Board for Business Resource Centers, The Kickstart Seed Fund, The Renaissance Foundation, The Edison Institute, SciTech the LES Board for Technology Commercialization Structure and Development and Alta Innovation Institute.